| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 126,565 | 120,398 | 118,131 | 162,827 | | Cost of Revenue | 100,380 | 98,520 | 98,302 | 133,081 | | | Gross Profit | 26,185 | 21,878 | 19,829 | 29,746 | | | Operating Expenses | | Research Development | 3,408 | 3,466 | 3,353 | 4,730 | | Selling General and Administrative | 16,494 | 15,243 | 16,620 | 19,353 | | Non Recurring |
-
|
-
| 35,396 | 1,883 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,283 | 3,169 | (35,540) | 3,780 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (373) | 6 | (251) | 1,007 | | Earnings Before Interest And Taxes | 5,910 | 3,175 | (35,791) | 4,787 | | Interest Expense | 256 | 471 | 888 | 766 | | Income Before Tax | 5,654 | 2,704 | (36,679) | 4,021 | | Income Tax Expense | 1,173 | 9,729 | (1,030) | (1,631) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,481 | (7,025) | (35,649) | 5,652 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,481 | (7,025) | (35,649) | 5,652 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,481 | ($7,025) | ($35,649) | $5,652 |
|
0.31% Nasdaq 0.00%
Income Statement
